Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients.

Pubmed ID: 12902815

Journal: Journal of acquired immune deficiency syndromes (1999)

Publication Date: Aug. 15, 2003

MeSH Terms: Humans, Adult, Female, HIV Infections, Middle Aged, HTLV-II Infections, Human T-lymphotropic virus 2, Viral Load, Anti-HIV Agents, Proviruses, Antiretroviral Therapy, Highly Active

Grants: N01-HB-57116, N01-HB-57117, N01-HB-57126, N01-HB-57127, N01-HB-57118, N01-HB-57119, N01-HB-57120, N01-HB-57121, N01-HB-57122, N01-HB-57123, N01-HB-57124, N01-HB-57125, N01-HB-571115, P30-MH59037, R01-HL62235

Authors: Busch MP, Lee TH, Murphy EL, Grant RM, Kropp J, Oliveira A

Cite As: Murphy EL, Grant RM, Kropp J, Oliveira A, Lee TH, Busch MP. Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients. J Acquir Immune Defic Syndr 2003 Aug 15;33(5):655-6.

Studies:

Abstract